BioPharma, Artificial Intelligence Roche, PicnicHealth start RWD partnership with multiple sclerosis focus By Alaric DeArment
BioPharma BMS gets FDA approval for multiple sclerosis drug, but Covid-19 delays rollout By Alaric DeArment
BioPharma, Legal Biogen fends off Mylan’s challenge to patent on top-selling multiple sclerosis drug By Alaric DeArment
BioPharma Sanofi’s billion-dollar multiple sclerosis drug faces competitive threat from Novartis, J&J agents By Alaric DeArment
Pharma, Startups MedDay raises $38.5M to kick off U.S. clinical trials for multiple sclerosis By Meghana Keshavan
Pharma, Startups Much like Biogen, Novoron developing drug to restore myelin sheaths in multiple sclerosis By Meghana Keshavan
Top Story, Daily Those who are prone to low vitamin D levels have an increased risk of multiple sclerosis By Nicole Oran
Pharma, Startups Neuro Vigor repurposing blood pressure drug for multiple sclerosis By Meghana Keshavan
Daily Purdue spinout developing drug that cuts down neurotoxin associated with multiple sclerosis By Meghana Keshavan
Hospitals Cleveland Clinic & Genzyme will jointly pursue new approaches to treating multiple sclerosis By
Devices & Diagnostics DioGenix picks up $3.2M in search of a clearer, earlier way to diagnose multiple sclerosis By
Devices & Diagnostics Molecular diagnostic firm wants to catch multiple sclerosis sooner and with greater accuracy By Arundhati Parmar
Diagnostics New molecular test in clinical trials could help physicians identify multiple sclerosis earlier By
